A Randomized, Double-blind, Parallel-group, Phase III Study of MRA-SC in Rheumatoid Arthritis Patients with Inadequate Response to Tocilizumab Subcutaneous Injection 162 mg every 2 weeks A Randomized, Double-blind, Parallel-group, Phase III Study of MRA-SCin Rheumatoid Arthritis Patient ...
Rheumatoid arthritis
Intervention name : MRA-SC INN of the intervention : tocilizumab Dosage And administration of the intervention : 162 mg QW Control intervention name : MRA-SC INN of the control intervention : tocilizumab Dosage And administration of the control intervention : 162 mg Q2W Intervention name : MRA-SC INN of the intervention : tocilizumab Dosage And administration of the inte ...